RI
ADVM

RTW Investments’s Adverum Biotechnologies ADVM Stock Holding History

RTW Investments’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-22,373
Closed -$293K – 108
2022
Q1 		$293K Sell
22,373
-733,109
-97% -$10.7M 0.01% 103
2021
Q4 		$13.3M Buy
755,482
+7,106
+0.9% +$142K 0.19% 76
2021
Q3 		$16.2M Buy
748,376
+12,584
+2% +$321K 0.24% 68
2021
Q2 		$25.8M Buy
735,792
+894
+0.1% +$48.2K 0.39% 53
2021
Q1 		$72.5M Buy
734,898
+12,162
+2% +$1.46M 1.13% 30
2020
Q4 		$78.3M Sell
722,736
-740
-0.1% -$91.6K 1.31% 24
2020
Q3 		$74.5M Buy
723,476
+44,473
+7% +$6.66M 1.79% 17
2020
Q2 		$142M Buy
679,003
+15,840
+2% +$2.81M 3.99% 5
2020
Q1 		$64.8M Buy
663,163
+24,502
+4% +$2.86M 2.79% 12
2019
Q4 		$73.6M Buy
638,661
+10,561
+2% +$931K 2.78% 11
2019
Q3 		$34.2M Sell
628,100
-3,935
-0.6% -$443K 2.04% 18
2019
Q2 		$75.1M Buy
632,035
+6,351
+1% +$526K 4.01% 8
2019
Q1 		$32.8M Hold
625,684
– – 2.24% 15
2018
Q4 		$19.7M Buy
625,684
+607,202
+3,285% +$24.7M 1.81% 16
2018
Q3 		$1.12M Buy
18,482
+845
+5% +$47.5K 0.07% 44
2018
Q2 		$935K Buy
17,637
+116
+0.7% +$6.98K 0.07% 39
2018
Q1 		$1.02M Buy
+17,521
New +$1.09M 0.1% 37
2015
Q2 		– Sell
-5,130
Closed -$2.08M – 36
2015
Q1 		$2.08M Buy
5,130
+130
+3% +$55K 0.94% 14
2014
Q4 		$2.7M Buy
+5,000
New +$1.93M 1% 14

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

RTW Investments's ADVM Position: Q2 2022 in Review

RTW Investments sold out of Adverum Biotechnologies (ADVM) in Q2 2022, closing a stake of 22,373 shares — an estimated $293K sold.

RTW Investments first reported a position in ADVM in Q4 2014 and held it in 19 quarters. The position peaked at $142M in Q2 2020. 77 funds tracked by Wall St. Rank hold ADVM as of Q2 2022.

  • RTW Investments reported no remaining Adverum Biotechnologies position as of Q2 2022 after selling out during the quarter.
  • RTW Investments sold 22,373 Adverum Biotechnologies shares in Q2 2022, an estimated $293K.
  • RTW Investments first reported a position in Adverum Biotechnologies in Q4 2014 and held it in 19 quarters.
  • RTW Investments's Adverum Biotechnologies position peaked at $142M in Q2 2020.
  • 77 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2022.

Based on RTW Investments's 13F filing for Q2 2022, filed 15 Aug 2022.